1
|
Paese EO, Rodriguez R, Azambuja AA. Alveolar Paratesticular Rhabdomyosarcoma in an Adult Patient With PAX3-FOXO1 Fusion and Unfavorable Evolution. Cureus 2024; 16:e71279. [PMID: 39529773 PMCID: PMC11551073 DOI: 10.7759/cureus.71279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/11/2024] [Indexed: 11/16/2024] Open
Abstract
Rhabdomyosarcomas, malignant mesenchymal tumors of skeletal striated muscle tissue cells, are usually rare in adults. However, when they occur in this population, the prognosis is usually poor, especially if the condition is associated with molecular factors such as the PAX3-FOXO1 fusion. Here, We report a case of paratesticular alveolar rhabdomyosarcoma in an adult patient who initially complained of increased scrotal volume for two years and presented with a PAX3-FOXO1 fusion. This emphasizes the dire prognosis of the disease, reinforcing the need for thorough and directed diagnostic efforts.
Collapse
Affiliation(s)
- Eduardo O Paese
- College of Medicine, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, BRA
| | | | - Alan A Azambuja
- Oncology, Pontifícia Universidade Católica Do Rio Grande Do Sul, Porto Alegre, BRA
| |
Collapse
|
2
|
Singh P, Anandani G, Parmar R. Primary paratesticular embryonal rhabdomyosarcoma - An unusual presentation. J Family Med Prim Care 2023; 12:2176-2180. [PMID: 38024875 PMCID: PMC10657067 DOI: 10.4103/jfmpc.jfmpc_397_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2023] [Revised: 06/26/2023] [Accepted: 06/28/2023] [Indexed: 12/01/2023] Open
Abstract
Paratesticular embryonal rhabdomyosarcoma (RMS) is a very rare and aggressive mesenchymal tumor. It is usually seen in children and adolescents presenting as a painless intrascrotal mass, localized in the paratesticular region. Hereby, we report two cases of paratesticular embryonal RMS in adults. One case was clinically suspected to be a testicular abscess, whereas the other presented with testicular swelling and lung metastasis. Localized forms have a good prognosis, whereas tumors presenting with metastases show a poor outcome. A treatment based on surgery and chemotherapy yields good results. Sperm cryopreservation and endocrine follow-up improve the overall survival and quality of life of these patients.
Collapse
Affiliation(s)
- Priyanka Singh
- Department of Pathology, VMMC and Safdarjung Hospital, New Delhi, India
| | - Garima Anandani
- Department of Pathology, All India Institute of Medical Sciences (AIIMS), Rajkot, Gujarat, India
| | - Riddhi Parmar
- Department of Pathology, All India Institute of Medical Sciences (AIIMS), Rajkot, Gujarat, India
| |
Collapse
|
3
|
Su P, Yang Y, Wang X, Chen S, Zhang N, Yang H. A case report of primary para-testicular spindle cell rhabdomyosarcoma. Front Oncol 2023; 13:1166503. [PMID: 37350935 PMCID: PMC10282740 DOI: 10.3389/fonc.2023.1166503] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2023] [Accepted: 05/22/2023] [Indexed: 06/24/2023] Open
Abstract
Para-testicular rhabdomyosarcoma (PTRMS) is a rare tumor, and it accounts for 7% of all rhabdomyosarcoma tumors. Among all the rhabdomyosarcoma (RMS) types, the spindle cell RMS is extremely rare. The present study describes a case of a para-testicular spindle cell RMS that was treated with a radical inguinal orchiectomy (RIO) and right scrotal resection. A 17-year-old male patient presented with a half-year history of a rapidly growing, painless, right scrotal mass. His CT of the pelvic cavity showed a mixed-density mass in the right scrotum, and the maximum cross-sectional area was approximately 76.5 mm × 64.5 mm. An X-ray of the chest demonstrated no evidence of metastasis, and a local surgical excision was performed subsequently. The histopathological and immunohistochemical examination confirmed the final diagnosis of spindle cell RMS. As a newly diagnosed case, strict and regular follow-up is needed. This article focuses on the importance of prompt recognition, diagnosis, pathological features, and appropriate management of para-testicular spindle cell RMS.
Collapse
Affiliation(s)
- Peng Su
- Department of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China
| | - Ying Yang
- Department of Dermatology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China
| | - Xiaomin Wang
- Department of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China
| | - Shulian Chen
- Department of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China
| | - Neng Zhang
- Department of Urology, The Affiliated Hospital of Zunyi Medical University, Zunyi, China
| | - Hua Yang
- Department of Pathology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China
| |
Collapse
|
4
|
Chalouati T, Ghalleb M, Jallali A, Slimane M, Sahraoui G, Ben hassouna J, Chargui R, Rahal K. Surgical resection of a massive residual retroperitoneal mass after chemotherapy for a paratesticular rhabdomyosarcoma: a case report. J Med Case Rep 2022; 16:476. [PMID: 36550579 PMCID: PMC9783374 DOI: 10.1186/s13256-022-03707-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2022] [Accepted: 12/02/2022] [Indexed: 12/24/2022] Open
Abstract
INTRODUCTION Paratesticular rhabdomyosarcoma is a rare and aggressive mesenchymal tumor, accounting for only 7% of all rhabdomyosarcomas. It is mainly encountered in children and adolescents. The standard treatment consists of radical orchidectomy with negative surgical margins. However, chemotherapy is recommended to control retroperitoneal micrometastasis. The place of surgery for progressive retroperitoneal lymph node metastases remains controversial. We present a case of paratesticular rhabdomyosarcoma with progressive retroperitoneal lymph node metastases treated with surgery. CASE REPORT We report a case of a 17-year-old North African male with no particular medical history who presented with a left scrotal mass that had been evolving for several months. Beta-human chorionic gonadotropin, alpha-fetoprotein, and lactate dehydrogenase were normal. Scrotal ultrasonography revealed the presence of a 6 cm heterogeneous hypoechogenic tissular mass with cystic areas adherent to the left scrotal wall, which was thickened in some places and vascularized by color Doppler. It exerted a mass effect on the homolateral testicle, which was of average volume. The thoracic-abdominal-pelvic computed tomography scan showed the presence of suspicious paraaortic lymph nodes. The most voluminous one measured 16 × 23 mm2. A left orchidectomy was performed. The final pathology report revealed an 8 cm paratesticular rhabdomyosarcoma of the embryonic type that displaced the testicle without invading it. Without going beyond it, it infiltrated the epididymis, the rete testis, and the albuginea. The surgical margin at the level of the spermatic cord was free. The patient had adjuvant chemotherapy (ifosfamide, vincristine, and dactinomycin). The patient had a challenging paraaortic lymph node dissection since the mass enlaced the left ureter and renal vessels. On histological examination, the paraaortic lymph nodes were metastatic. CONCLUSION Rhabdomyosarcoma is an aggressive malignancy with high metastatic potential. Therefore, only an accurate diagnosis and early treatment can ensure better survival. Surgery in expert hands seems to be a good option for progressive retroperitoneal nodes. However, further studies are needed to determine the place of surgery in this setting.
Collapse
Affiliation(s)
- Takoua Chalouati
- Surgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| | - Montassar Ghalleb
- Surgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| | - Amani Jallali
- Surgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| | - Maher Slimane
- Surgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| | - Ghada Sahraoui
- Histology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| | - Jamal Ben hassouna
- Surgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| | - Riadh Chargui
- Surgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| | - Khaled Rahal
- Surgical Oncology Department, Salah Azaiez Institute of Oncology, Tunis, Tunisia ,grid.12574.350000000122959819Faculty of Medicine of Tunis, University Tunis El Manar, Tunis, Tunisia
| |
Collapse
|